Dr. Cooper's Publications/Abstracts   Dr. Chet Cooper Associate Professor Email: crcooper01@ysu.edu Tel.: 330.941.1361 Fax: 330.941.1483 Go to the desired section of this web page by pressing the appropriate button Link to YSU Proteomics Research Group Web Page Back to Dr. Cooper's Home Page Family, Friends, Avocations, and (of course!) Jack Dog   Mailing Address:   Department of Biological Sciences Youngstown State University One University Plaza Youngstown, Ohio   44555 U.S.A.   Viewing This Web Page: This web page was produced using the Composer function of Netscape 7.2.  In additon to Netscape 7.2, Safari 1.0.3 appears to read this page well.  However, the structural layout and integrity of this document may vary with other as yet untested browsers. Copyright © 2007 Chester R. Cooper, Jr. Buttons used in this web page were created using Buttongenerator.

---

---

1.	COOPER CR Jr, Harris JL, Jacobs CW, Szaniszlo PJ. Effects of polyoxin AL on cellular development in Wangiella dermatitidis. Exp Mycol 8:349-363, 1984. [Abstract]
2.	Nelson, M, COOPER CR, Crowley DE, Reid CPP, Szaniszlo PJ. An Escherichia coli bioassay of individual siderophores in soil. J Plant Nutr 11:915-924, 1988.
3.	Salkin IF, COOPER CR Jr, Bartges JW, Kemna ME, Rinaldi, MR. Scedosporium inflatum osteomyelitis in a dog. J Clin Microbiol 30:2797-2800, 1992. [Entrez-PubMed Citation] (Free full text article available via this link)
4.	Dixon DM, Migliozzi J, COOPER CR Jr, Solis O, Breslin B, Szaniszlo PJ. Melanized and non-melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies. Mycoses 35:17-21, 1992. [Entrez-PubMed Citation]
5.	COOPER CR Jr, Breslin BJ, Dixon DM, Salkin IF. DNA typing of isolates associated with the 1988 sporotrichosis epidemic. J Clin Microbiol 30:1631-1635, 1992. [Entrez-PubMed Citation] (Free full text article available via this link)
6.	COOPER CR Jr, Dixon DM, Salkin IF. Laboratory-acquired sporotrichosis. J Med Vet Mycol 30:169-171, 1992. [Entrez-PubMed Citation]
7.	Supparatpinyo E, Nelson KE, Merz WG, Breslin BJ, COOPER CR Jr, Sirisanthana T. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei. Infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother 37:2407-2411, 1993. [Entrez-PubMed Citation] (Free full text article available via this link)
8.	COOPER CR Jr, Szaniszlo PJ. Evidence for two cell division cycle (CDC) genes that govern yeast bud emergence in the pathogenic fungus Wangiella dermatitidis. Infect Immun 61:2069-2081, 1993. [Entrez-PubMed Citation] (Free full text article available via this link)
9.	Lenon PA, COOPER CR Jr, Salkin IF, Lee SB. Ribosomal DNA internally transcribed spacer analysis supports synonomy of Scedosporium inflatum and Lomentospora prolificans. J Clin Microbiol 32:2413-2416, 1994. [Entrez-PubMed Citation] (Free full text article available via this link) [Back to Top of Page]
10.	Salkin IF, McGinnis MR, COOPER CR Jr, Rippon JW, Beneke ES. Current priorities for the clinical mycology laboratory. J Med Vet Mycol 32(Supplement #1):309-319, 1994. [Entrez-PubMed Citation]
11.	Rex JH, COOPER CR Jr, Merz WG, Anaissie EJ. Detection of amphotericin B-resistant Candida species in a broth-based system. Antimicrob Agents Chemother 39:906-909, 1995. [Entrez-PubMed Citation] (Free full text article available via this link)
12.	Pfaller MA, Bole M, Buschelman B, Lancaster M, Espinel-Ingroff A, Rex JH, Rinaldi MG, COOPER CR, McGinnis MR. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and 5-fluorocytosine. J Clin Microbiol 33:1104-1107, 1995. [Entrez-PubMed Citation] (Free full text article available via this link)
13.	Peng M, COOPER CR Jr, Szaniszlo PJ. Genetic transformation of the dematiaceous phaeohyphomycotic fungus Wangiella dermatitidis. Appl Microbiol Biotechnol 44:440-450, 1995. [Entrez-PubMed Citation]
14.	Vanittanakom N, COOPER CR Jr, Chariyalertsak S, Youngchim S, Nelson KE, Sirisanthana T. Restriction endonuclease analysis of Penicillium marneffei. J Clin Microbiol 34:1834-1836, 1996. [Entrez-PubMed Citation] (Free full text article available via this link)
15.	COOPER CR, McGinnis MR. In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole. Am J Obstet Gynecol 175:1626-1631, 1996. [Entrez-PubMed Citation]   (password required to open document)
16.	Espinel-Ingroff A, Bowden R, Meneses P, Bartlett M, McGinnis M, COOPER C, Odds F, Pfaller M, Messer BS, Rex J, Nelson P, Rinaldi M, Fothergill A, Shankland J, Walsh T, Peter J, Weitzman I, Chin NX. A multicenter evaluation of the standardization of antifungal susceptibility testing for the filamentous fungi. J Clin Microbiol 35:139-143, 1997. [Entrez-PubMed Citation] (Free full text article available via this link)
17.	Odds FC, Rinaldi MG, COOPER CR, Fothergill A, Pasarell L, McGinnis MR. Candida and Torulopsis. A blinded evaluation of use of pseudohypha formation as a basis for identification of medically important yeasts. J Clin Microbiol 35:313-316, 1997. [Entrez-PubMed Citation] (Free full text article available via this link)
18,	McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, COOPER CR Jr, Rinaldi MG. In vitro evaluation of voriconazole against some clinically important fungi. Anitmicrob Agents Chemother 41:1832-1834, 1997. [Entrez-PubMed Citation] (Free full text article available via this link)
19.	Hajjeh R, McDonnell S, Reef S, Licitra C, Hankins M, Toth B, Padye A, Kaufman L, Pasarell L, COOPER C, Hutwagner L, Hopkins R, McNeil M. An outbreak of lymphocutaneous sporotrichosis among nursery workers associated with topiary production. J Infect Dis 176:499-504, 1997. [Entrez-PubMed Citation]   (password required to open document) [Back to Top of Page]
20.	COOPER CR Jr, McGinnis MR. Penicillium marneffei, an emerging acquired immunodeficiency syndrome-related pathogen. Arch Pathol Lab Med 121:798-804, 1997. [Entrez-PubMed Citation]
21.	McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, COOPER CR Jr, Rinaldi MG. In vitro evaluation of voriconazole against selected fungi.  Med Mycol 36:239-242, 1998. [Entrez-PubMed Citation]  [OhioLink PDF Full Text Link] (requires access to OhioLink system)
22.	Haubold EM, Aronson JF, Cowan DF, McGinnis MR, COOPER CR Jr. Isolation of fungal rDNA from bottlenose dolphin skin infected with Loboa loboi. Med Mycol 36: 263-267, 1998. [Entrez-PubMed Citation]  [OhioLink PDF Full Text Link] (requires access to OhioLink system)
23.	Nelson KE, Kaufman L, COOPER CR, Merz WG. Penicillium marneffei: infection and biology. Infect Med 16: 118-121, 128, 1999. [On-Line Full-Text Article via Medscape]
24.	COOPER CR Jr, Haycocks NG. Penicillium marneffei: an insurgent species among the penicillia. J Euk Microbiol. 47: 24-28, 2000. [Entrez-PubMed Citation]  [OhioLink PDF Full Text Link] (requires access to OhioLink system)
25.	Haubold EM, COOPER CR Jr, Wen JW, McGinnis MR, Cowan DF. Comparative morphology of Lacazia loboi (syn. Loboa loboi) in dolphins and humans. Med Mycol. 38: 9-14, 2000. [Entrez-PubMed Citation]  [OhioLink PDF Full Text Link] (requires access to OhioLink system)
26.	Restrepo A, Baumagardner DJ, Bagagli E, COOPER CR Jr, McGinnis MR, Lazera MS, Barbosa FH, Bosco SMG, Camargo ZPF, Coelho KIR, Fortes ST, Franco M, Montenegro MR, Sano A, Wanke B. Clues to the presence of pathogenic fungi in certain environments. Med Mycol 38(Supplement #1): 67-77, 2000. [Entrez-PubMed Citation]  [OhioLink PDF Full Text Link] (requires access to OhioLink system)
27.	Pongpom, P., COOPER, C. R., Jr, and Vanittanakom, N. Isolation and Characterization of a yeast-phase specific catalase-peroxidase gene from the pathogenic fungus, Penicillium marneffei. Med Mycol 43:403-411, 2005. [Entrez-PubMed Citation]  [OhioLink PDF Full Text Link] (requires access to OhioLink system)
28.	Vanittanakom, N., COOPER, C. R., Jr,, Fisher, M. C., and Sirisanthana, T. Penicillium marneffei infection and recent advances in the molecular biology aspect. Clin Microbiol Rev 19:95-110, 2006. [Entrez-PubMed Citation] (Free full text article available via this link)
29.	Thirach, S., COOPER, C. R., Jr., Vanittanakom P., and Vanittanakom N.  Isolation and characterization of a superoxide-dismutase gene from the pathogenic fungus, Penicillium marneffei.  Med Mycol 45:409-417, 2007. [Entrez-PubMed Citation]
30.	D’Elia, T.V., COOPER, C. R., Jr., and Johnston, C. G.  Source tracking of Escherichia coli by 16S-23S intergenic spacer region denaturing gradient gel electrophoresis (DGGE) of the rrnB ribosomal operon.  Can J Microbiol 53:1174-1184, 2007. [Entrez-PubMed Citation]
31.	Liu, H., Abramczyk, D., COOPER, C. R., Jr., Zheng, L., Park, C., and Szaniszlo, P. J. 2008. Molecular cloning and characterization of WdTUP1, a gene that encodes a potential transcriptional repressor important for yeast-hyphal transitions in Wangiella (Exophiala) dermatitidis. Fungal Genet Biol [in press]
32.	COOPER, C. R., Jr., and Vanittanakom N.  2008.  Insights into the pathogenicity of Penicillium marneffei.  Future Microbiol. [in press]

1.	Szaniszlo PJ, Geis PA, Jacobs CW, COOPER CR Jr, Harris JL. Cell-wall changes associated with yeast-to-multicullular-form conversion in Wangiella dermatitidis. In: Schlessinger D, ed. Microbiology 1983. Washington, DC: American Society for Microbiology, p. 239-244, 1983.
2.	Haines JH, COOPER CR Jr. DNA and mycological herbaria. In: Reynolds DR, Taylor JW, eds. The fungal holomorph: Mitotic, meiotic and pleomorphic speciation in fungal systematics. Wallingford, United Kingdom: CAB International, pp. 305-315, 1993.
3.	COOPER CR Jr. Phase transition in Wangiella dermatitidis: Identification of cell-division-cycle genes involved in yeast bud emergence. In: Vanden Bossche H, Kerridge D, Odds F, eds. Dimorphic fungi in biology and medicine. London: Plenum Press, pp. 105-119, 1993.
4.	COOPER CR Jr, Salkin IF. Pseudallescheriasis. In: Murphy JW, Bendinelli M, Friedman H, eds. Fungal infections and immune responses. New York: Plenum Press, pp. 335-358, 1993.
5.	COOPER CR Jr, Szaniszlo, PJ. Spheroplast fusion in Wangiella dermatitidis. In: Maresca B, Kobayashi G, eds. Molecular biology of pathogenic fungi. A laboratory manual. New York: Telos Press, pp. 527-531, 1994.
6.	COOPER CR Jr, Szaniszlo PJ. A spectrophotometric assay for orotidine-5'-monophosphate pyrophosphorylase activity in Wangiella dermatitidis. In: Maresca B, Kobayashi G, eds. Molecular biology of pathogenic fungi. A laboratory manual. New York: Telos Press, pp. 537-543, 1994.
7.	COOPER CR Jr, Szaniszlo PJ. Melanin as a virulence factor in dematiaceous pathogenic fungi. In: Vanden Bossche H, Stevens DA, Odds FC, eds., Proceedings of the 5th symposium in mycology: Host-fungus interplay. Bethesda, MD: National Foundation for Infectious Diseases, pp. 81-93, 1997.
8.	COOPER CR Jr. New and emerging pathogens - What can the lab do? In: Cihlar RL, Calderone, RA, eds., Fungal pathogenesis: principles and clinical applications. New York: Marcel Dekker, pp. 751-757, 2001.
9.	Haubold EM, COOPER CR Jr, McGinnis MR, Cowan DF. Molecular identification of the infective agent of Lobo’s disease of dolphins. In: Pfeiffer CJ, ed. Cell and Molecular and Cell Biology of Marine Mammals. Malabar, Florida: Kreiger Publishing Company, pp. 186-192, 2002.
10.	COOPER CR Jr. 2005. Deep phaeohyphomycosis. In: Merz WG, Hay RJ, eds., Topley and Wilson’s Microbiology and Microbial Infections. Vol 4. Medical Mycology, 10th ed. London, pp. 739-748, 2005.
11.	COOPER, C. R., Jr.  2008.  Yeasts Pathogenic for Humans and Animals. In: Kurtzman, C, Fell J, Berkhout, R, eds.,  The Yeasts: A Taxonomic Study, 5th ed.  London [in press].

 

1.	COOPER CR Jr.  From bamboo rats to humans: the odyssey of Penicillium marneffei. ASM News  64: 390-397, 1998.

1.	Wang JY, COOPER CR, Harris JL, Szaniszlo PJ. Effects of polyoxin on yeast and multicellular-form development of Wangiella dermatitidis. American Society for Microbiology, Atlanta, Georgia, March 1982. [poster presentation]
2.	Szaniszo PJ, Harris JL, COOPER CR, Schafer RC, Jacobs CW. Cellular development in Wangiella dermatitidis. Third International Mycological Congress, Tokyo, Japan, August-September 1983. [poster presentation]
3.	Schafer RC, COOPER CR Jr, Szaniszlo PJ. Complementation of two multicellular genes from Wangiella dermatitidis. American Society for Microbiology, St. Louis, Missouri, March 1984. [poster presentation]
4.	COOPER CR Jr, Szaniszlo PJ. Genetic evidence for cell-division-cycle (CDC) control of multicellular development in Wangiella dermatitidis. Mycological Society of America, Ottawa, Canada, June 1987. [poster presentation]
5.	Szaniszlo PJ, Reid CPP, Crowley DE, Newlson MN, COOPER CR. Kinetics of plant iron uptake from microbial siderophores in relation to siderophore quantities in nature. Mycological Society of America, Ottawa, Canada, June 1987. [poster presentation]
6.	Nelson M, COOPER CR, Crowley DE, Reid CPP, Szaniszlo PJ. Bioassay for individual siderophores in soil. Fourth International Symposium on Iron Nutrition and Interactions in Plants, Albuquerque, New Mexico, July 1987. [poster presentation]
7.	COOPER CR Jr. Confirmation of cell-division-cycle (CDC) genes in Wangiella dermatitidis by segregant analysis of MBC-treated, spheroplast-fusion products. American Society for Microbiology, Miami, Florida, May 1988. [oral presentation]
8.	COOPER CR Jr, Harris JL, Szaniszlo PJ. Restriction fragment polymorphisms of intact chromosomes to differentiate dematiaceous fungi. American Society for Microbiology, Miami, Florida, May 1988. [poster presentation]
9.	COOPER CR Jr, Szaniszlo PJ. Evidence for diploidy in Wangiella dermatitidis, a pathogen of humans. Mycological Society of America, Davis, California, August 1988. [oral presentation] [Back to Top of Page]
10.	COOPER CR Jr, Harris JL, Szaniszlo PJ. Differentiation of clinical strains of dematiaceous yeasts by restriction fragment polymorphisms. Mycological Society of America, Davis, California, August 1988. [poster presentation]
11.	COOPER CR Jr, Szaniszlo PJ. Biochemical and genetic characterization of uracil auxotrophs derived from the pathogenic fungus Wangiella dermatitidis. American Society for Microbiology, Anaheim, California, May 1990. [oral presentation]
12.	COOPER CR Jr. Parasexual genetic analysis of cell division cycle mutants responsible for phase transition in Wangiella dermatitidis. Fourth International Mycological Congress, Regensberg, Germany, August 1990. [oral presentation]
13.	Dixon DM, Migliozzi J, COOPER CR Jr, Solis O, Breslin B, Szaniszlo PJ. Melanized and non-melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies. American Society for Microbiology, Dallas, Texas, May 1991. [poster presentation]
14.	Limberger, RJ, Cronin, K, COOPER CR Jr: Genomic megabase restriction endonuclease mapping of Treponema phagedenis strains Kazan 5 and Reiter. American Society for Microbiology, Dallas, Texas, May 1991. [poster presentation]
15.	COOPER CR Jr, Breslin BJ, Dixon DM, Salkin IF. DNA typing of strains associated with 1988 multistate (U.S.) sporotrichosis epidemic. 11th Congress of the International Society of Human and Animal Mycology, Montreal, Quebec, Canada, June 1991. [poster presentation]
16.	COOPER CR Jr, Dixon DM, Salkin IF. Laboratory-acquired sporotrichosis. 11th Congress of the International Society for Human and Animal Mycology, Montreal, Quebec, Canada, June 1991. [poster presentation]
17.	COOPER CR Jr, Lapa EW, Gordon MA.  Antifungal susceptibility testing: a reference laboratory's experience. 11th Congress of the International Society for Human and Animal Mycology, Montreal, Quebec, Canada, June 1991. [poster presentation]
18.	COOPER CR Jr, DeVost J, Breslin BJ, Dixon DM. DNA typing of the emerging pathogen, Candida krusei. NATO Advanced Research Workshop “Molecular Biology and Its Application to Medical Mycology,” Taormina, Sicily, Italy, January 1992. [poster presentation]
19.	Salkin IF, COOPER CR, Kemna M, Rinaldi R, Bartges JW. Scedosporium inflatum osteomyelitis in a dog. American Society for Microbiology, New Orleans, Louisiana, May 1992. [poster presentation]
20.	COOPER CR Jr. Phase transition in Wangiella dermatitidis. Fourth Symposium on “Topics in Mycology: Fungal Dimorphism,” Cambridge, United Kingdom, September 1992. [oral presentation]
21.	Lennon PA, Lee SB, COOPER CR, Salkin IF. Comparative DNA restriction and sequence analysis of Scedosporium inflatum and Lomentosora prolificans. American Society for Microbiology, Atlanta, Georgia, May 1993. [poster presentation] [Back to Top of Page]
22.	Kemna ME, COOPER CR Jr, Neri RC, Salkin IF. Cokeromyces recurvatus isolated from an endo-cervical specimen. American Society for Microbiology, Atlanta, Georgia, May 1993. [poster presentation]
23.	Supparatpinyo K, Nelson K, Merz W, Breslin B, COOPER C Jr, Sirisanthana T. Correlation of in vitro susceptibility and response to antifungal therapy in AIDS patients with disseminated Penicillium marneffei infection in Thailand. Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, October 1993. [poster presentation]
24.	COOPER C Jr, Breslin B, Nelson K, Merz W, Supparatpinyo K, Sirisanthana T. In vitro susceptibility testing of Penicillium marneffei and correlation to patient response. International Summit on Cutaneous Antifungal Therapy, San Francisco, CA, October 1993. [poster presentation]
25.	COOPER CR Jr. New technologies and their application in clinical mycology. 12th Congress of the International Society for Human and Animal Mycology, Adelaide, Australia, March 1994. [oral presentation]
26.	Lennon PA, COOPER CR Jr, Lee SB, Salkin IF. rDNA ITS analyses provides identification of Scedosporium inflatum, Lomentospora prolificans, S. apiospermum and Pseudallescheria boydii. Fifth International Mycological Congress, Vancouver, British Columbia, August 1994. [poster presentation]
27.	COOPER CR Jr. Molecular epidemiology of fungal infections. Fifth International Mycological Congress, Vancouver, British Columbia, August 1994. [oral presentation]
28.	COOPER CR Jr. The clinical relevance of molecular technology to the practicing clinician treating/diagnosing mycoses. Second International Summit on Cutaneous Antifungal Therapy, Boston, MA, November 1994. [oral presentation]
29.	COOPER CR Jr. Opportunistic and saprophytic moulds. Second International Summit on Cutaneous Antifungal Therapy, Boston, MA, November 1994. [oral presentation]
30.	COOPER CR Jr, McGinnis MR, Salkin IF. Development of a PCR-based assay to differentiate Scedosporium prolificans from Scedosporium apiospermum. American Society for Microbiology, Washington, DC, May 1995. [poster presentation]
31.	COOPER CR Jr, McGinnis MR. In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole. American Society for Microbiology, Washington, DC, May 1995. [poster presentation]
32.	COOPER CR Jr, Fothergill AW, McGinnis MR, McGough DA, Padhye AA, Rinaldi MG, Salkin IF. Physiologic and genetic variation of four clinical isolates of Scedosporium. American Society for Microbiology, Washington, DC, May 1995. [poster presentation]
33.	Pfaller M, Bale M, Buschelman B, Lancaster M, Espinel-Ingroff A, Rex J, Rinaldi M, COOPER CR Jr, McGinnis MR. Quality control guidelines for NCCLS broth macrodilution testing of amphotericin B, fluconazole, and 5-fluorocytosine. American Society for Microbiology, Washington, DC, May 1995. [poster presentation] [Back to Top of Page]
34.	COOPER CR Jr. Melanin as a virulence factor in dematiaceous pathogenic fungi. Fifth Symposium on “Topics in Mycology: Host-Fungus Interplay,” Stanford, CA, June 1995. [oral presentation]
35.	COOPER CR Jr. Chitin synthase gene fragments from Penicillium marneffei. Fifth Symposium on “Topics in Mycology: Host-Fungus Interplay,” Stanford, CA, June 1995. [poster presentation]
36.	COOPER CR Jr, McGinnis MR. In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole. Infectious Diseases Society for Obstetrics and Gynecology, Traverse City, MI, August 1995. [poster presentation]
37.	COOPER CR Jr, McGinnis MR. In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole. Third International Symposium on Cutaneous Fungal, Bacterial, and Viral Infection and Therapy, San Francisco, CA, September 1995. [poster presentation]
38.	McGinnis MR, Pasarell L, COOPER CR Jr. In vitro susceptibility of clinical mould isolates to UK-109,496, amphotericin B, fluconazole and itraconazole. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, September 1995. [poster presentation]
39.	Fiskin AM, Rinaldi MG, COOPER CR, McGinnis MR. Substrains of pathogenic Rhizopus differentiable by molecular probes and by SEM surface morphology. Infectious Diseases Society of America, San Francisco, California, September 1995. [poster presentation]
40.	COOPER CR Jr, McGinnis MR, Kemna M, Buchholz MA, Elewski BE. The reservoir effect of oxiconazole nitrate, 1% cream (OXC) in protecting against Trichophyton mentagrophytes infection. American Academy of Dermatology, Washington, DC, February 1996. [poster presentation]
41.	COOPER CR Jr. Identification of chitin synthase homologues from Penicillium marneffei. American Society for Microbiology, New Orleans, Lousiana, May 1996. [poster presentation]
42.	COOPER CR Jr. In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole. Fourth Annual Congress on Women’s Health, Washington, DC, June 1996. [poster presentation]
43.	Haycocks NG, COOPER CR Jr, McGinnis MR. Evidence for a chitin synthase gene from Madurella mycetomatis. American Society for Microbiology, Miami, Florida, May 1997. [poster presentation]
44.	Haubold EM, Cowan DF, COOPER CR Jr, McGinnis MR. Unusual mycotic infections in stranded western Gulf of Mexico dolphins: phaeohyphomycosis and lobomycosis. Proceedings of 28th Annual International Association for Aquatic Animal Medicine, Harderwijk, The Netherlands, May 1997. [oral presentation]
45.	Szaniszlo PJ, Peng M, COOPER CR Jr, Zheng L, Wang Z, Ye XC. Transformation and gene disruption in Wangiella dermatitidis. 13th Congress of the International Society for Human and Animal Mycology, Salsomaggiore Terme, Parma, Italy, June 1997. [oral presentation] [Back to Top of Page]
46.	McGinnis MR, Pasarell L, COOPER CR Jr. In vitro susceptibility of clinical dematiaceous fungal isolates against terbinafine, itraconazole, and amphotericin B. Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada. October 1997. [poster presentation]
47.	Nunn GB, COOPER CR, McGinnis M, Smith DH, Dodge DE. Diagnosis of clinically imporant fungal pathogens by direct DNA sequencing - a phylogenetic approach using ‘expansion segment’ sequences. Association for Molecular Pathology, San Diego, California, November 1997. [poster presentation]
48.	Haubold EM, COOPER CR, McGinnis MR, Cowan DF. Comparative morphology of Loboa loboi in Tursiops truncatus and human cutaneous lesions: are they really the same? World Marine Mammal Science Conference, Monaco. January 1998. [oral presentation]
49.	Nunn GB, Smith DH, Collins PJ, COOPER CR, McGinnis MR, Lévesque CA, McKemy J, Dodge DE. Fungal species diagnostics – a universal phylogenetic approach using expansion segment sequences. American Society for Microbiology, Atlanta, Georgia, May 1998. [poster presentation]
50.	McGinnis MR, Nunn GB, COOPER CR. Correlation of voriconazole susceptibility to phylogeny of pathogenic moulds and dimorphic fungi. European Congress in Medical Mycology, Glasgow, Scotland, May 1998. [poster presentation]
51.	COOPER CR Jr, Haycocks NG. Dimorphism in the emerging pathogen Penicillium marneffei. Sixth International Mycological Congress, Jerusalem, Israel, August 1998. [oral presentation]'
52.	COOPER CR Jr. Penicillium marneffei: clinical and epidemiological aspects. Focus on Fungal Infections, San Diego, California, March 1999. [oral presentation]
53.	COOPER CR Jr, Haycocks NG. Penicillium marneffei as an Emerging OI. 52nd Annual Meetings, Society of Protozoologists, Raleigh, North Carolina, May 1999 [oral presentation]
54.	Haycocks, NG, McGinnis MR, COOPER CR Jr. Thermally regulated gene expression in the pathogenic fungus Penicillium marneffei. American Society for Microbiology, Chicago, Illinois, May/June 1999. [poster presentation]
55.	COOPER CR Jr. The connections between bamboo rats and Penicillium marneffei. 14th Congress of the International Society for Human and Animal Mycology, Buenos Aires, Argentina, May 2000. [oral presentation was given by Dr. Michael McGinnis due to my unavoidable absence from the Congress]
56.	Haycocks NG, McGinnis MR, COOPER CR Jr. Identification of a differentially regulated malate synthase homologue in Penicillium marneffei. American Society for Microbiology, Los Angeles, California, May 2000. [poster presentation]
57.	Haycocks NG, COOPER CR Jr., McGinnis MR. Molecular characterization of two glyoxylate cycle genes of Penicillium marneffei. American Society for Microbiology, Salt Lake City, Utah, May 2001. [poster presentation] [Back to Top of Page]
58.	Thomas L, COOPER CR Jr., Usis J, Johnston C. The characterization andecological succession of indigenous yeast in a Chardonnay fermentation of an Ohio winery. American Society for Microbiology, Orlando, Florida, May 2002. [poster presentation]
59.	COOPER CR Jr., Gifford, TD. Electrophoretic karyotype of Penicillium marneffei. 15th Congress of the International Society for Human and Animal Mycology, San Antonio, Texas, May 2003. [poster presentation]
60.	Thirach S, COOPER CR, Vanittanakom N. Phagocytosis and killing of Penicillium marneffei by human peripheral blood leukocytes. 15th Congress of the International Society for Human and Animal Mycology, San Antonio, Texas, May 2003. [poster presentation]
61.	Vanittanakom N, Pongpom P, COOPER CR, Fisher MC, Hay RJ. Penicillium marneffei: past, present and future identification methods. 15th Congress of the International Society for Human and Animal Mycology, San Antonio, Texas, May 2003. [oral presentation]
62.	Pongpom P, COOPER CR, Uparanukraw P, Sittisombut N, Vanittanakom N. Cloning and analysis of genes encoding immunogenic proteins of Penicillium marneffei. 15th Congress of the International Society for Human and Animal Mycology, San Antonio, Texas, May 2003. [poster presentation]
63.	Gifford T, COOPER CR Jr., Ran Y, Lasker, BA. Use of a telomeric DNA probe to type clinical and environmental isolates of the dimorphic fungal pathogen Penicillium marneffei. Annual Meeting of the American Society for Microbiology, New Orleans, LA. May 2004. [poster presentation]
64.	Kim TD, Trenary H, Chandler J, COOPER CR Jr. Proteomic profiling of dimorphism in Penicillium marneffei. International Union of Biochemistry and Molecular Biology/American Society of Biochemistry and Molecular Biology, Boston, MA, June 2004. [poster presentation]
65.	Kim TD, Brown D, Kim TD, COOPER CR Jr. Proteomic profiling of Wangiella dermatitidis. International Union of Biochemistry and Molecular Biology/American Society of Biochemistry and Molecular Biology, Boston, MA, June 2004. [poster presentation]
66.	COOPER CR Jr., Kim TD, Walker GR. Fungal proteomics as an interdisciplinary undergraduate research program. 10th National Conference of the Council of Undergraduate Research in La Crosse, Wisconsin. June 2004. [poster presentation]
67.	D’Elia T, COOPER CR Jr., Johnston CG.  Source Tracking of Escherichia coli by Denaturing Gradient Gel Electrophoresis (DGGE) of the 16S-23S Intergenic Spacer Region of the rrnB Ribosomal Operon.  International Society for Microbial Ecology, Cancun, Mexico.  August 2004. [poster presentation]
68.	COOPER CR Jr., Kim TD, Walker GR. Proteomic profiling of dimorphism in the pathogenic fungus, Penicillium marneffei. First International Fungal Proteomics Symposium, Portland, Oregon. October 2004. [oral presentation]
69.	Walker GR, Pizzino S, Segna K, Kim TD, COOPER CR Jr. Analysis of the Penicillium marneffei secretome: the proteomics of an opportunistic pathogen. American Society for Cell Biology, San Franscico, California. December 2005. [poster presentation]
70.	Chandler JM, Treece ER, Kim TD, Walker GR, COOPER CR Jr. Yeast phase protein profiling of the dimorphic fungal pathogen, Penicillium marneffei. ASM Conference on Dimorphic Fungal Pathogens, Denver, Colorado. March 2006. [poster presentation] [Back to Top of Page]
71.	Chandler JM, Segna K, Walker GR, Kim TD, COOPER CR Jr. Dimorphic changes in the Penicillium marneffei secretome: The possible identification of a serine peptidase specific for the pathogenic yeast form. ASM Conference on Dimorphic Fungal Pathogens, Denver, Colorado. March 2006. [poster presentation]
72.	COOPER CR Jr., Chandler JM, Treece ER, Kim TD, Walker GR. Protein profiling of dimorphism in the fungal pathogen, Penicillium marneffei. Eighth International Mycological Congress, Carins, Australia. August 22, 2006. [oral presentation]
73.	Thirach, S. COOPER CR Jr., Vanittanakom N. Phagocytosis and killing of human pathogenic Penicillium marneffei and Penicillium sp. by mouse macrophage J774.1 cells. Eighth International Mycological Congress, Carins, Australia. August 22, 2006. [poster presentation]
74.	Chandler JM, Treece ER, Kim TD, COOPER CR Jr., Coschigano PW. Proteomic Analysis of Anaerobic p-Cresol Metabolism by Thauera aromatica strain T1. Annual Meeting of the American Society for Microbiology, Toronto, Ontario, Canada.  May 2007. [poster presentation]
75.	Lee, M, Chandler JM, COOPER CR Jr., Walker GR, Volk TJ.  Proteomic profiling of dimorphism in Penicillium marneffei, an opportunistic fungal pathogen of humans.  Mycological Society of America in Baton Rouge, Louisiana.  August 2007 [poster presentation]
76.	Chandler JM, Treece ER, Frommelt JL, Trenary HR, Kim TD, COOPER CR Jr., Walker GR.  Changes in fungal protein populations during the temperature induced dimorphic switch in Penicillium marneffei. American Society for Cell Biology, Washington, DC.  December 2007. [poster presentation]